Université de Technologie de Compiègne, CNRS, Biomechanics and Bioengineering, Centre de Recherche Royallieu CS 60319, 60203 Compiègne Cedex, France.
CNRS IRL 2820, Laboratory for Integrated Micro Mechatronic Systems, Institute of Industrial Science, University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo, 153-8505, Japan.
Lab Chip. 2022 Jun 28;22(13):2423-2450. doi: 10.1039/d2lc00307d.
The liver is a key organ that plays a pivotal role in metabolism and ensures a variety of functions in the body, including homeostasis, synthesis of essential components, nutrient storage, and detoxification. As the centre of metabolism for exogenous molecules, the liver is continuously exposed to a wide range of compounds, such as drugs, pesticides, and environmental pollutants. Most of these compounds can cause hepatotoxicity and lead to severe and irreversible liver damage. To study the effects of chemicals and drugs on the liver, most commonly, animal models or 2D cell cultures are used. However, data obtained from animal models lose their relevance when extrapolated to the human metabolic situation and pose ethical concerns, while 2D static cultures are poorly predictive of human metabolism and toxicity. As a result, there is a widespread need to develop relevant liver models for toxicology studies. In recent years, progress in tissue engineering, biomaterials, microfabrication, and cell biology has created opportunities for more relevant models for toxicology studies. Of these models, the liver organ-on-chip (OoC) has shown promising results by reproducing the behaviour of the cell/organ or a group of organs, the controlled physiological micro-environment, and cellular metabolic responses. In this review, we discuss the development of liver organ-on-chip technology and its use in toxicity studies. First, we introduce the physiology of the liver and summarize the traditional experimental models for toxicity studies. We then present liver OoC technology, including the general concept, materials used, cell sources, and different approaches. We review the prominent liver OoC and multi-OoC integrating the liver for drug and chemical toxicity studies. Finally, we conclude with the future challenges and directions for developing or improving liver OoC models.
肝脏是一个关键的器官,在新陈代谢中起着至关重要的作用,确保了身体的各种功能,包括内稳态、必需成分的合成、营养物质储存和解毒。作为外源性分子代谢的中心,肝脏不断暴露于广泛的化合物中,如药物、农药和环境污染物。这些化合物中的大多数都会导致肝毒性,并导致严重和不可逆转的肝损伤。为了研究化学物质和药物对肝脏的影响,通常使用动物模型或 2D 细胞培养物。然而,从动物模型中获得的数据在推断到人类代谢情况时失去了相关性,并引发了伦理问题,而 2D 静态培养物对人类代谢和毒性的预测能力较差。因此,广泛需要开发相关的毒理学研究肝脏模型。近年来,组织工程、生物材料、微制造和细胞生物学的进展为毒理学研究提供了更相关的模型机会。在这些模型中,肝器官芯片 (OoC) 通过复制细胞/器官或一组器官的行为、受控的生理微环境和细胞代谢反应,显示出有前途的结果。在这篇综述中,我们讨论了肝器官芯片技术的发展及其在毒性研究中的应用。首先,我们介绍了肝脏的生理学,并总结了毒性研究的传统实验模型。然后我们介绍了肝 OoC 技术,包括一般概念、使用的材料、细胞来源和不同的方法。我们回顾了突出的肝 OoC 和多器官集成肝用于药物和化学毒性研究。最后,我们总结了开发或改进肝 OoC 模型的未来挑战和方向。